IKE Capital’s Pfizer PFE Stock Holding History

IKE Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$274K	Buy	+11,000	New	+$277K	0.24%	66

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

IKE Capital's PFE Position: Q4 2025 in Review

IKE Capital opened a new position in Pfizer (PFE) in Q4 2025: 11,000 shares worth $274K. The stake represents 0.24% of the portfolio and ranks #66 among its holdings.

2,913 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

IKE Capital held 11,000 shares of Pfizer worth $274K as of Q4 2025.
Pfizer was a new IKE Capital position in Q4 2025.
Pfizer made up 0.24% of IKE Capital's portfolio in Q4 2025, its #66 holding.
2,913 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on IKE Capital's 13F filing for Q4 2025, filed 19 Aug 2026.